Minerva Common Stock Shares Outstanding from 2010 to 2024

NERV Stock  USD 2.44  0.01  0.41%   
Minerva Neurosciences Common Stock Shares Outstanding yearly trend continues to be fairly stable with very little volatility. Common Stock Shares Outstanding will likely drop to about 4.6 M in 2024. Common Stock Shares Outstanding is the total number of shares of a company's common stock that are currently owned by all its shareholders. View All Fundamentals
 
Common Stock Shares Outstanding  
First Reported
2013-03-31
Previous Quarter
7.6 M
Current Value
6.5 M
Quarterly Volatility
1.3 M
 
Yuan Drop
 
Covid
Check Minerva Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Minerva main balance sheet or income statement drivers, such as Depreciation And Amortization of 29.5 K, Interest Expense of 8.7 M or Selling General Administrative of 10.9 B, as well as many exotic indicators such as Price To Sales Ratio of 1.86, Dividend Yield of 0.0366 or Days Sales Outstanding of 0.0. Minerva financial statements analysis is a perfect complement when working with Minerva Neurosciences Valuation or Volatility modules.
  
This module can also supplement various Minerva Neurosciences Technical models . Check out the analysis of Minerva Neurosciences Correlation against competitors.
For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.

Latest Minerva Neurosciences' Common Stock Shares Outstanding Growth Pattern

Below is the plot of the Common Stock Shares Outstanding of Minerva Neurosciences over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. Minerva Neurosciences' Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Minerva Neurosciences' overall financial position and show how it may be relating to other accounts over time.
Common Stock Shares Outstanding10 Years Trend
Slightly volatile
   Common Stock Shares Outstanding   
       Timeline  

Minerva Common Stock Shares Outstanding Regression Statistics

Arithmetic Mean3,928,621
Geometric Mean3,622,491
Coefficient Of Variation38.56
Mean Deviation1,322,082
Median4,564,563
Standard Deviation1,514,901
Sample Variance2.3T
Range4.9M
R-Value0.89
Mean Square Error525.2B
R-Squared0.79
Significance0.00001
Slope300,606
Total Sum of Squares32.1T

Minerva Common Stock Shares Outstanding History

20244.6 M
20236.5 M
20225.3 M
20215.3 M
20205.1 M
20194.9 M
20184.8 M

About Minerva Neurosciences Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Minerva Neurosciences income statement, its balance sheet, and the statement of cash flows. Minerva Neurosciences investors use historical funamental indicators, such as Minerva Neurosciences's Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Although Minerva Neurosciences investors may use each financial statement separately, they are all related. The changes in Minerva Neurosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Minerva Neurosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Minerva Neurosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Minerva Neurosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Shares Outstanding6.5 M4.6 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Minerva Neurosciences is a strong investment it is important to analyze Minerva Neurosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Minerva Neurosciences' future performance. For an informed investment choice regarding Minerva Stock, refer to the following important reports:
Check out the analysis of Minerva Neurosciences Correlation against competitors.
For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Minerva Stock analysis

When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Is Minerva Neurosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Minerva Neurosciences. If investors know Minerva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Minerva Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.61)
Return On Assets
(0.26)
Return On Equity
(6.75)
The market value of Minerva Neurosciences is measured differently than its book value, which is the value of Minerva that is recorded on the company's balance sheet. Investors also form their own opinion of Minerva Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Minerva Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Minerva Neurosciences' market value can be influenced by many factors that don't directly affect Minerva Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Minerva Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Minerva Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Minerva Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.